[ Price : $8.95]
FDA accepts a Telix Pharmaceuticals resubmitted NDA for TLX101-Px, an investigational PET imaging agent for glioma.[ Price : $8.95]
FDA cites significant manufacturing and quality control deficiencies at an active pharmaceutical ingredient facility operated by O...[ Price : $8.95]
FDA cautions BioCorRx about false and misleading information on the Web site home page for its Lucemyra.[ Price : $8.95]
Vanda Pharmaceuticals says FDA should withdraw a legislative proposal in its budget package that the company says would lengthen N...[ Price : $8.95]
FDA and the device industry are nearing a final agreement on the next round of Medical Device User Fee Act (MDUFA VI) negotiations...[ Price : $8.95]
Medline Industries recalls (Class 1) its angiographic control syringes, warning the devices could cause severe injury or death.[ Price : $8.95]
Two Hyman, Phelps & McNamara attorneys describe the impacts on industry if FDA responds to a congressional push for more pre-revie...[ Price : $8.95]
HHS secretary Robert F. Kennedy Jr. curtails his public commentary on vaccines as part of a deliberate political strategy by the T...